12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

1 de July de 2025

In accordance with Ordinance 03/2025, published by the BPTO on March 25, 2025, a new limit of 800 Patent Prosecution Highway (PPH) … New PPH Cycle Opens for Third Quarter of 2025 – Telecommunication Applications Excluded

1 de July de 2025

On Thursday, June 26, the Brazilian Supreme Federal Court (STF) issued a landmark ruling, partially invalidating Article 19 of the Brazilian Internet … Brazil’s Supreme Court Partially Strikes Down Internet Law Provision, Imposes Stricter Duty of Care on Online Platforms

24 de June de 2025

In Brazil, the holder of intellectual property rights is entitled not only to economically exploit their work, but also to monitor how … Software License Compliance: A Constitutional and Strategic Right

Kasznar Leonardos